Stay updated with breaking news from Frank Duff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Findings from PBC, HDV, HCV, HBV and MASH/Fibrosis Studies Affirm Commitment to Drive Life-changing Science in Liver Disease - Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research
The US FDA has granted approval for Gilead Sciences’ sNDA for Vemlidy 25mg tablets to treat chronic hepatitis B virus (HBV) in paediatric patients.
The new indication includes pediatric patients aged 6 years and older who weigh at least 25 kg and have compensated liver disease.
Remembering Snowmageddon. A desire for daycares. The importance of diverse housing types. New standards for old churches. Getting serious about harm reduction.
A renowned doctor, and husband of a former St. John's mayor, was remembered during the regular council meeting...